Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Roberge

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 30, 2022
<sup>68</sup>Ga-DOTATATE PET: The Future of Meningioma TreatmentRahul N Prasad, Haley K Perlow, Joseph Bovi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2009
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patientsPaul W Sperduto, Samuel T Chao, Penny K Sneed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2023
Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical TrialsHeng Li, Nina A Mayr, Robert J Griffin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2012
In regard to Yamamoto et alPaul W Sperduto, Penny K Sneed, David Roberge, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Journal of Neuro-Oncology|April 17, 2016
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastasesGlenn Bauman, Slav Yartsev, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2025
Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
The Lancet. Oncology|September 8, 2024
Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 studyLaura A Dawson, Jolie Ringash, Alysa Fairchild, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|June 30, 2022
<sup>68</sup>Ga-DOTATATE PET: The Future of Meningioma TreatmentRahul N Prasad, Haley K Perlow, Joseph Bovi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2009
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patientsPaul W Sperduto, Samuel T Chao, Penny K Sneed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2023
Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical TrialsHeng Li, Nina A Mayr, Robert J Griffin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2012
In regard to Yamamoto et alPaul W Sperduto, Penny K Sneed, David Roberge, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Journal of Neuro-Oncology|April 17, 2016
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastasesGlenn Bauman, Slav Yartsev, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2025
Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
The Lancet. Oncology|September 8, 2024
Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 studyLaura A Dawson, Jolie Ringash, Alysa Fairchild, et al.
Pageof 17